Search for: "Eli Lilly & Company"
Results 1 - 20 of 369
Sorted by Relevance | Sort by Date
10 Jun, 2005 4:52 pm
The New York Times reported today that Eli Lilly & Company has agreed to settle thousands of lawsuits based upon the medication, Zyprexa, used to treat schizophrenia and bipolar disorder. The times reports
that Zyprexa is Eli Lilly's "biggest selling drug," and that plaintiffs claimed they developed
diabetes and ... of the cases filed and includes both state and federal claims. Interestingly, Eli Lilly intends to keep Zyprexa on the market. The exact details are not clear yet, but ...
6 Jan, 2007 3:22 pm
In an ongoing battle with the controversial drug Zyprexa, Eli Lilly & Co. has agreed to settle
another 18,000 of the cases pending against them that resulted in their patients developing diabetes and other serious health conditions. In 2005, Eli Lilly & Co., settled another 8,000 lawsuits against it for $700 million after Zyprexa's risks were exposed
to the public. Although this settlement is not expected ...
9 Jun 11:39 am
... of Indiana, Indianapolis Division, on behalf of a nationwide group of current and former employees of Eli Lilly Company. At the same time, the plaintiffs filed an amended complaint alleging that the pharmaceutical giant
discriminates against its ... declarations. "As these individual and collective employment experiences make clear, for several decades Lilly
has intentionally engaged in discriminatory practices with indifference to the federally protected rights of its African American employees," ...
7 Oct, 2008 4:01 pm
NEW YORK (AP) _ Eli Lilly & Co. said Tuesday it will pay $62 million to resolve investigations
into the marketing and promotion of its antipsychotic drug Zyprexa in 32 states and Washington, D.C. The ... more than $100 per year for promotional speaking or consulting regarding
Zyprexa, and agreed to other promotional terms. A group of insurance companies, unions and others are currently suing the Indianapolis-based drugmaker for billions of dollars,
saying Lilly charged too much for Zyprexa and ...
30 Jan 3:27 am
... stimulant drugs used for treating ADHD have been problematic. During those years of seeming FDA complacence, pharmaceutical companies accumulated huge profits by pushing
stimulant pills to kids, and for different reasons, to adults as well. The term ... be noted that credible estimates of the percent of adverse reactions that are reported range from
1-10%). It is certainly not so that Eli Lilly had received these reports in the period February -
June 2005. Almost all of reports had been received in ...
16 Oct, 2008 9:05 pm
... physicians can prescribe drugs to patients for uses that are not FDA-approved, drug companies are not allowed to market medications for off-label purposes. Dangerous Drug
Litigation ... into the marketplace while knowing it was potentially dangerous and marketed the medication for profit. Eli Lilly settles Zyprexa inquiries in 32 states, AP, October 7, 2008 ... ad claims, The Bismark Tribune, May 21, 2008 Related Web Resources: Eli Lilly and Company Zyprexa North Carolina Attorney General Roy Cooper
16 Jan 12:30 pm
... were urged to promote use of Zyprexa for use in dementia patients. Documents produced in court have shown that the company greedily pushed
Zyprexa to treat a variety of disorders that it was never approved for, including aggression, dementia and dementia related ... is in addition to the previous one. Eli Lilly's greed for profits at the cost of the health of thousands of patients isn't the first instance of
corporate greed by a pharmaceutical company, but it was astonishing in how widespread and ...
26 Oct 1:36 am
... included more details about the settlement between South Carolina and drug manufacturer Eli Lilly
with regard to allegations of off-label marketing for the drug Zyprexa. The settlement was $45 ... state has won from Eli Lilly, per the article cut and pasted below. S.C., Lilly reach $45 million settlement Drug company's payout ... s office. It's also the largest dollar amount any state has won from Eli Lilly. Connecticut is second with its $30 million settlement. "This is a victory for South Carolina's ...
15 Jan 6:39 pm
... of Columbia. Zyprexa was FDA approved in 1996 for treatment of bipolar disorder and schizophrenia in adults but the company has since
marketed the drug for off-label (unapproved, often untested) uses. These include Zyprexa for ... from other unintended side effects of Zyprexa. And yet Zyprexa not only remains on the
market but remains the company's best selling drug. The present Zyprexa settlement developed out of two qui tam whistleblower cases against
Eli Lilly. As Medicare, Medicaid, and other ...
15 Jan 7:24 pm
... giant, Eli Lilly and Company, plead guilty to promoting
its drug Zyprexa for "off-label" uses. The plea resulted in the company paying $515 million in criminal fines. This is the largest payment made
from an individual corporate criminal fine in history. In ... 800 million payout to resolve the original qui tam lawsuits brought against the company. Although the drug was approved to treat manifestations of psychotic disorders, Eli Lilly taught their sales force to convince doctors to use the drug for ...
13 Apr 1:45 am
... government fraud procedure. My ofifce has its first qui tam case underway. Eli Lilly agrees to
pay $1.4 Billion in Qui tam fraud involving ... individual corporation ever imposed in a United States criminal prosecution of any kind. Eli
Lilly will also pay up to $800 million in a civil settlement with the federal government ... Anderson Kill Olick, who was not involved in the
Zyprexa case told us it would. "Companies that do any kind of business with the federal government should make sure that their ...
20 Nov, 2007 2:47 pm
... perhaps believing the generic versions have less of the critical ingredient(s). Whatever underlies the perceptions, pharmaceutical companies continually recognize the value
of patented drugs in their yearly profits. However, a pharmaceutical company cannot monopolize the ... , market analysts watch drug
companies closely--and measure their worth by a factor of whether and when their drug patents will expire and what new patents are in the works. With several of Eli Lilly's blockbuster drug patents ...
20 Dec, 2006 10:00 am
... e-mail messages among top company managers. The documents, given to The Times by a lawyer representing mentally ill patients, show that
Lilly executives kept important information from doctors about Zyprexa's links to obesity and its tendency to raise blood sugar - both known
risk factors for diabetes. (link) To the Editor: "Eli Lilly Said to Play Down Risk of Top Pill"
(front page, Dec. 17), about the company's decision to cover up health effects of its top-selling ...
30 Jan, 2008 8:22 am
... billion last year, is approved to treat people with schizophrenia and severe bipolar disorder. But documents from Eli Lilly show that the company has encouraged doctors to prescribe Zyprexa to people with age-related dementia, as well
as people with ... expert, an Alaska lawyer and a New York Times reporter for attempting to circumvent a protective order concerning internal Lilly documents. Those documents led to a lengthy NYT article at the end of 2006 outlining Lilly's marketing efforts
for the ...
8 Sep, 2008 1:40 pm
... NYT: A federal district judge in Brooklyn (ED NY) ruled yesterday that confidential marketing materials belonging to Eli Lilly & Company about its top-selling anti-psychotic drug Zyprexa must be returned to the company by a doctor ... after Weinstein derided the "conspiracy" orchestrated by Berenson and two sympathetic attorneys to obtain the documents -- primarily
internal Lilly documents and e-mails between its top managers -- the judge ordered the documents unsealed. "Public access is now ...
29 Apr 12:44 pm
... side effects of Zyprexa, Georgia made the decision to enter into a multimillion-dollar settlement with Eli Lilly and Co. Georgia will get more than six million dollars ... if Georgia is making the right decision. Many of the lawsuits filed against Eli Lilly and Co. contend the company has misled patients and physicians
about Zyprexa's ... . These side effects include diabetes, hyperglycemia and excessive weight gain. The company has denied any wrongdoing in
these civil cases. Apparently, Thurbert Baker, ...
29 Nov, 2008 8:16 pm
... Lilly program is modeled after federal legislation authored by Senate Aging Committee Chairman Herb Kohl (D-Wis.) and Finance Committee
ranking member Chuck Grassley (R-Iowa). Lilly decided to advance the transparency policies on its own because policymakers and the public are
demanding drug companies be more open. Read: Jeffrey Young, The Hill, 9-24-08, Eli Lilly to
disclose financial ties to doctors
14 Feb, 2007 5:27 am
... Brooklyn (ED NY) ruled yesterday that confidential marketing materials belonging to Eli Lilly
& Company about its top-selling anti-psychotic drug Zyprexa must be returned ... today in the NY Times. More from the story: The documents
were part of evidence provided by Lilly as part of a lawsuit filed by patients who claimed that side effects from Zyprexa caused excessive ...
has denied. He wrote front-page articles based on the information. Eli Lilly has now paid $1.2
billion to settle more than 28 ...
23 Mar, 2007 3:21 pm
... ILB has had a number of entries (see list here) on Lilly's drug Zyprexa. Most recently was this entry from Feb. 14th, 2007 on the 78-page
ED ... decision , holding that, to quote the NY Times, "confidential marketing materials belonging to Eli Lilly & Company about its top-selling anti-psychotic drug Zyprexa must be returned ... -selling anti-psychotic
drug Zyprexa. The plaintiffs claim that the drug's maker, Eli Lilly, gave inadequate warnings
regarding the risk of obesity and diabetes in Zyprexa ...
31 Jan, 2008 3:46 am
The New York Times is reporting that drug maker Eli Lilly is in settlement talks with the federal
government regarding the company's marketing of the antipsychotic drug Zyprexa. The talks could result in Lilly's paying more ... may also plead guilty to a misdemeanor criminal charge as part of the agreement, the people involved with the investigation said. But
the company would be allowed to keep selling Zyprexa to Medicare and Medicaid, the government programs that are the biggest customers for the
...
Search on: Blawgs.FM | BlawgSearch Google Co-op | Blawg.com | Bloglines | Feedster | Google Blog Search | Technorati | Google | MSN | Yahoo!